Researchers from Massachusetts Institute of Technology (MIT; MA, USA) have developed a novel nanoparticle that can increase the effectiveness of a type of immunotherapy cancer therapy. The team demonstrated that treating mice with existing drugs – termed checkpoint inhibitors – with their nanoparticles was more effective at treating cancer than when just the drug was used alone. These results could allow for cancer immunotherapy to benefit a greater percentage of patients as they are currently only effective for a small portion. The human immune system is capable of recognizing and destroying abnormal cells such as cancer cells. However, many tumors...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!